| Literature DB >> 26031508 |
Qijun Du1,2, Tengchuang Ma3, Changhui Fu1, Tianlong Liu1, Zhongbing Huang2, Jun Ren1, Haibo Shao3, Ke Xu3, Fangqiong Tang1, Xianwei Meng1.
Abstract
The combination of therapies and monitoring the treatment process has become a new concept in cancer therapy. Herein, gelatin-based microcapsules have been first reported to be used as microwave (MW) susceptible agent and magnetic resonance (MR) imaging contrast agent for cancer MW thermotherapy. Using the simple coacervation methods, ionic liquid (IL) and Fe3O4 nanoparticles (NPs) were wrapped in microcapsules, and these microcapsules showed good heating efficacy in vitro under MW irradiation. The results of cell tests indicated that gelatin/IL@Fe3O4 microcapsules possessed excellent compatibility in physiological environments, and they could effectively kill cancer cells with exposure to MW. The ICR mice bearing H22 tumors treated with gelatin/IL@Fe3O4 microcapsules were obtained an outstanding MW thermotherapy efficacy with 100% tumor elimination under ultralow density irradiation (1.8 W/cm(2), 450 MHz). In addition, the applicability of the microcapsules as an efficient contrast agent for MR imaging in vivo was evident. Therefore, these multifunctional microcapsules have a great potential for MR imaging-guided MW thermotherapy.Entities:
Keywords: MR imaging-guided; MW thermotherapy; gelatin microcapsules; ionic liquid; tumor
Mesh:
Substances:
Year: 2015 PMID: 26031508 DOI: 10.1021/acsami.5b03230
Source DB: PubMed Journal: ACS Appl Mater Interfaces ISSN: 1944-8244 Impact factor: 9.229